Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia

Fabian, Carol J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Division of Cancer Prevention And Control (NCI)
• Type: Research and Development Contracts (N01)
• Project #: N01CN065124-003
• Application #: 6292648
• Project Start: 1996-09-26
• Project End: 2000-06-30
• Budget Start: 2000-03-15
• Budget End: 2000-06-30
• Fiscal Year: 1999

Institution

• Name: University of Kansas
• Department: Pharmacology
• Type: Schools of Medicine
• DUNS #: 016060860
• City: Kansas City
• State: KS
• Country: United States
• Zip Code: 66160

Publications

Fabian, Carol J; Kimler, Bruce F; Brady, Deborah A et al. (2002) A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clin Cancer Res 8:3105-17